semaglutide patent expiry europe Ozempic just got much, much cheaper in India. On March 21, Danish company Novo Nordisk's on semaglutide, the active ingredient behind its diabetes and weight-loss drugs Ozempic and Wegovy, expired in Peptide Biosimilars: What Happens When

Patients striving for weight loss are now more aware of medications like semaglutide (the main ingredient in Ozempic and Wegovy) , thanks to their viral burst into media as adorn celebrities shed significant weight suddenly and quickly

Sodhi and his colleagues examined health insurance claims to find people who had obesity, but not diabetes, and took GLP-1 agonists including semaglutide, the active ingredient in Ozempic and Wegovy or another type of weight-loss drug, bupropion-naltrexone, between 2006 and 2020

No safety guarantees Perhaps most importantly, once semaglutide passes its expiration date, the manufacturer no longer guarantees its strength, quality, or purity

A vial labeled as 5mg of semaglutide sodium contains slightly less active semaglutide by weight than a vial labeled as 5mg semaglutide base

I have been long LLY and NVO because of GLP-1 drugs since early 2022, but as evidence continues to amass in favour of their utility for a large population its worth considering - what other implications does this have